2022
SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study (Journal article)
Nayar, M., Varghese, C., Kanwar, A., Siriwardena, A. K., Haque, A. R., Awan, A., . . . Grp, C. O. V. I. D. P. C. (2022). SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study. GUT, 71(7), 1444-1447. doi:10.1136/gutjnl-2021-326218DOI: 10.1136/gutjnl-2021-326218
Kui, B., Pinter, J., Molontay, R., Nagy, M., Farkas, N., Gede, N., . . . Grp, H. P. S. (2022). EASY-APP: An artificial intelligence model and application for early and easy prediction of severity in acute pancreatitis. CLINICAL AND TRANSLATIONAL MEDICINE, 12(6). doi:10.1002/ctm2.842DOI: 10.1002/ctm2.842
de Rijk, F. E. M., van Veldhuisen, C. L., Besselink, M. G., van Hooft, J. E., van Santvoort, H. C., van Geenen, E. J. M., . . . Dutch Pancreatitis Study Group. (2022). Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study. . Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 22(4), 457-465. doi:10.1016/j.pan.2022.03.013DOI: 10.1016/j.pan.2022.03.013
Stott, M. C., Oldfield, L., Hale, J., Costello, E., & Halloran, C. M. (2022). Recent advances in understanding pancreatic cancer.. Faculty reviews, 11, 9. doi:10.12703/r/11-9DOI: 10.12703/r/11-9
Bellomo, G., Rainer, C., Quaranta, V., Astuti, Y., Raymant, M., Boyd, E., . . . Schmid, M. C. (n.d.). Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis. Gut. doi:10.1136/gutjnl-2021-325272DOI: 10.1136/gutjnl-2021-325272
Pergolini, I., Schorn, S., Goess, R., Novotny, A. R., Ceyhan, G. O., Friess, H., . . . Zerbi, A. (2022). Drain use in pancreatic surgery: Results from an international survey among experts in the field. Surgery. doi:10.1016/j.surg.2021.11.023DOI: 10.1016/j.surg.2021.11.023
Oldfield, L., Evans, A., Rao, R. G., Jenkinson, C., Purewal, T., Psarelli, E. E., . . . Costello, E. (2022). Blood levels of adiponectin and IL-1Ra distinguish type 3c from type 2 diabetes: Implications for earlier pancreatic cancer detection in new-onset diabetes. EBIOMEDICINE, 75. doi:10.1016/j.ebiom.2021.103802DOI: 10.1016/j.ebiom.2021.103802
Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis (Journal article)
Moran, R. A., Halloran, C., Guo, Q., Umapathy, C., Jalaly, N. Y., Jain, S., . . . Singh, V. K. (2022). Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis. PANCREATOLOGY, 22(1), 67-73. doi:10.1016/j.pan.2021.11.003DOI: 10.1016/j.pan.2021.11.003
2021
McLean, K. A., Kamarajah, S. K., Chaudhry, D., Gujjuri, R. R., Raubenheimer, K., Trout, I., . . . Collaborative, C. (2021). Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic. BRITISH JOURNAL OF SURGERY, 108(12), 1448-1464. doi:10.1093/bjs/znab336DOI: 10.1093/bjs/znab336
Baron, R. D., Sheel, A. R. G., Farooq, A., Kleeff, J., Contin, P., Halloran, C. M., & Neoptolemos, J. P. (2021). The in situ near-total pancreatectomy (LIVOCADO procedure) for end-staged chronic pancreatitis. LANGENBECKS ARCHIVES OF SURGERY, 406(8), 2657-2668. doi:10.1007/s00423-021-02107-xDOI: 10.1007/s00423-021-02107-x
Aughton, K., Elander, N. O., Evans, A., Jackson, R., Campbell, F., Costello, E., . . . Greenhalf, W. (2021). hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. CANCERS, 13(22). doi:10.3390/cancers13225758DOI: 10.3390/cancers13225758
Glasbey, J. C., Ademuyiwa, A., Adisa, A., AlAmeer, E., Arnaud, A. P., Ayasra, F., . . . SICO, I. S. S. O. (2021). Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study. LANCET ONCOLOGY, 22(11), 1507-1517. doi:10.1016/S1470-2045(21)00493-9DOI: 10.1016/S1470-2045(21)00493-9
Probst, P., Huettner, F. J., Meydan, O., Abu Hilal, M., Adham, M., Barreto, S. G., . . . Diener, M. K. (2021). Evidence Map of Pancreatic Surgery-A living systematic review with meta-analyses by the International Study Group of Pancreatic Surgery (ISGPS). SURGERY, 170(5), 1517-1524. doi:10.1016/j.surg.2021.04.023DOI: 10.1016/j.surg.2021.04.023
Marchegiani, G., Barreto, S. G., Bannone, E., Sarr, M., Vollmer, C. M., Connor, S., . . . Shrikhande, S. V. (2021). Postpancreatectomy Acute Pancreatitis (PPAP). Annals of Surgery, Publish Ahead of Print. doi:10.1097/sla.0000000000005226DOI: 10.1097/sla.0000000000005226
Halloran, C. (n.d.). SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study. Gut. doi:10.1136/gutjnl-2020-323364DOI: 10.1136/gutjnl-2020-323364
Heckler, M., Hackert, T., Hu, K., Halloran, C. M., Buechler, M. W., & Neoptolemos, J. P. (2021). Severe acute pancreatitis: surgical indications and treatment. LANGENBECKS ARCHIVES OF SURGERY, 406(3), 521-535. doi:10.1007/s00423-020-01944-6DOI: 10.1007/s00423-020-01944-6
Ashworth, M., Small, B., Oldfield, L., Evans, A., Greenhalf, W., Halloran, C., & Costello, E. (2021). The holding temperature of blood during a delay to processing can affect serum and plasma protein measurements. SCIENTIFIC REPORTS, 11(1). doi:10.1038/s41598-021-85052-5DOI: 10.1038/s41598-021-85052-5
Glasbey, J. C., Omar, O., Nepogodiev, D., Minaya-Bravo, A., Bankhead-Kendall, B. K., Fiore, M., . . . SICO, I. S. S. O. (2021). Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic. BRITISH JOURNAL OF SURGERY, 108(1), 88-96. doi:10.1093/bjs/znaa051DOI: 10.1093/bjs/znaa051
Saunders, R., Hughes, F. E., Evans, J. C., Smart, H. L., Ghaneh, P., Ramesh, J., . . . Halloran, C. M. (2021). Cost analysis and outcomes of endoscopic, minimal access and open pancreatic necrosectomy. . Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2(2), e068. doi:10.1097/as9.0000000000000068DOI: 10.1097/as9.0000000000000068
Glasbey, J. C., & Bhangu, A. (n.d.). Elective Cancer Surgery in COVID-19–Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study. Journal of Clinical Oncology, JCO.20.01933. doi:10.1200/jco.20.01933DOI: 10.1200/jco.20.01933
Saunders, R., Neoptolemos, J. P., Hughes, F., Ghaneh, P., & Halloran, C. M. (2021). Single port retroperitoneal pancreatic necrosectomy for the treatment of extra-pancreatic walled off necrotic collections. . Annals of surgery open : perspectives of surgical history, education, and clinical approaches, 2(1), e019. doi:10.1097/as9.0000000000000019DOI: 10.1097/as9.0000000000000019
2020
Delaying surgery for patients with a previous SARS-CoV-2 infection (Journal article)
Collaborative, C. (2020). Delaying surgery for patients with a previous SARS-CoV-2 infection. BRITISH JOURNAL OF SURGERY, 107(12), E601-E602. doi:10.1002/bjs.12050DOI: 10.1002/bjs.12050
Szatmary, P., Arora, A., Raraty, M. G. T., Dunne, D. F. J., Baron, R. D., & Halloran, C. M. (2020). Emerging Phenotype of Severe Acute Respiratory Syndrome-Coronavirus 2-associated Pancreatitis. GASTROENTEROLOGY, 159(4), 1551-1554. doi:10.1053/j.gastro.2020.05.069DOI: 10.1053/j.gastro.2020.05.069
Lanzillotta, M., Vinge-Holmquist, O., Overbeek, K. A., Poulsen, J. L., Demirci, A. F., Macinga, P., . . . Rosendahl, J. (n.d.). PrescrAIP: A Pan-European Study on Current Treatment Regimens of Auto-Immune Pancreatitis. Frontiers in Medicine, 7. doi:10.3389/fmed.2020.00408DOI: 10.3389/fmed.2020.00408
Halloran, C. M. (n.d.). Prognostic value of 18FDG PET-CT volumetric parameters in the survival prediction of patients with pancreatic cancer. Annals of Surgical Oncology. doi:10.1016/j.ejso.2020.02.002DOI: 10.1016/j.ejso.2020.02.002
Pereira, S. P., Oldfield, L., Ney, A., Hart, P. A., Keane, M. G., Pandol, S. J., . . . Costello, E. (2020). Early detection of pancreatic cancer. The Lancet Gastroenterology and Hepatology, 5(7), 698-710. doi:10.1016/S2468-1253(19)30416-9DOI: 10.1016/S2468-1253(19)30416-9
Barrera, L. N., Evans, A., Lane, B., Brumskill, S., Oldfield, F. E., Campbell, F., . . . Costello, E. (2020). Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties.. Cancer Research, 80(13), 2861-2873. doi:10.1158/0008-5472.can-19-3534DOI: 10.1158/0008-5472.can-19-3534
Mel Wilcox, C., Gress, T., Boermeester, M., Masamune, A., Lévy, P., Itoi, T., . . . International (IAP-APA-JPS-EPC) Consensus Guidelines for Chronic Pancreatitis. (2020). International consensus guidelines on the role of diagnostic endoscopic ultrasound in the management of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club.. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 20(5), 822-827. doi:10.1016/j.pan.2020.05.025DOI: 10.1016/j.pan.2020.05.025
Miao, Y., Lu, Z., Yeo, C. J., Jr, V. C. M., Fernandez-del Castillo, C., Ghaneh, P., . . . ISGPS, I. S. G. P. S. (2020). Management of the pancreatic transection plane after left (distal) pancreatectomy: Expert consensus guidelines by the International Study Group of Pancreatic Surgery (ISGPS). SURGERY, 168(1), 72-84. doi:10.1016/j.surg.2020.02.018DOI: 10.1016/j.surg.2020.02.018
Greenhalf, W., Lévy, P., Gress, T., Rebours, V., Brand, R. E., Pandol, S., . . . Neoptolemos, J. (2020). International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club. Pancreatology. doi:10.1016/j.pan.2020.05.011DOI: 10.1016/j.pan.2020.05.011
Mahajan, U. M., Goni, E., Langhoff, E., Li, Q., Costello, E., Greenhalf, W., . . . Mayerle, J. (2020). Cathepsin D Expression and Gemcitabine Resistance in Pancreatic Cancer.. JNCI cancer spectrum, 4(1), pkz060. doi:10.1093/jncics/pkz060DOI: 10.1093/jncics/pkz060
ESPAC-5F: Four Arm, Prospective, Multicenter, International Randomized Phase II Trial of Immediate Surgery Compared With Neoadjuvant Gemcitabine Plus Capecitabine (GEMCAP) or FOLFIRINOX or Chemoradiotherapy (CRT) in Patients With Borderline Resectable Pancreatic Cancer (Conference Paper)
Ghaneh, P., Palmer, D., Cicconi, S., Halloran, C. M., Jackson, R., Rawcliffe, C., . . . Neoptolemos, J. P. (2020). ESPAC-5F: Four Arm, Prospective, Multicenter, International Randomized Phase II Trial of Immediate Surgery Compared With Neoadjuvant Gemcitabine Plus Capecitabine (GEMCAP) or FOLFIRINOX or Chemoradiotherapy (CRT) in Patients With Borderline Resectable Pancreatic Cancer. In PANCREAS Vol. 49 (pp. 1410). Retrieved from http://gateway.webofknowledge.com/
2019
Neoptolemos, J. P., Ghaneh, P., Kleeff, J., Halloran, C. M., & Büchler, M. W. (2019). Response to Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma'' by Niccolo Petrucciani, MD, PhD, FACS, Laura Antolino, MD, Giovanni Moschetta, MD, Giovanni Ramacciato, MD, FACS. ANNALS OF SURGERY, 270(06), E130-E131. doi:10.1097/SLA.0000000000003371DOI: 10.1097/SLA.0000000000003371
Sheel, A. R. G., Baron, R. D., Dickerson, L. D., Ghaneh, P., Campbell, F., Raraty, M. G. T., . . . Neoptolemos, J. P. (2019). The Liverpool duodenum-and spleen-preserving near-total pancreatectomy can provide long-term pain relief in patients with end-stage chronic pancreatitis. LANGENBECKS ARCHIVES OF SURGERY, 404(7), 831-840. doi:10.1007/s00423-019-01837-3DOI: 10.1007/s00423-019-01837-3
Jones, R. P., Psarelli, E. -E., Jackson, R., Ghaneh, P., Halloran, C. M., Palmer, D. H., . . . Canc, E. S. G. P. (2019). Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA SURGERY, 154(11), 1038-1048. doi:10.1001/jamasurg.2019.3337DOI: 10.1001/jamasurg.2019.3337
Muller, N., Sarantitis, I., Rouanet, M., de Mestier, L., Halloran, C. M., & Greenhalf, W. (2019). Natural history of SPINK1 germline mutation related-pancreatitis. EBioMedicine, 48, 581-591. doi:10.1016/j.ebiom.2019.09.032DOI: 10.1016/j.ebiom.2019.09.032
Saunders, R., Ramesh, J., Cicconi, S., Evans, J., Yip, V. S., Raraty, M., . . . Halloran, C. (2019). A systematic review and meta-analysis of metal versus plastic stents for drainage of pancreatic fluid collections: metal stents are advantageous. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 33(5), 1412-1425. doi:10.1007/s00464-018-6416-5DOI: 10.1007/s00464-018-6416-5
Olesen, S. S., Krarup, H., Poulsen, J. L., Christensen, J. H., Sheel, A. R. G., Sutton, R., . . . Drewes, A. M. (2019). Pancreas-specific plasma amylase for assessment and diagnosis of chronic pancreatitis: New insights on an old topic. United European Gastroenterology Journal. doi:10.1177/2050640619846011DOI: 10.1177/2050640619846011
Mann, K., Gilbert, T., Cicconi, S., Jackson, R., Whelan, P., Campbell, F., . . . Ghaneh, P. (2019). Tumour stage and resection margin status are independent survival factors following partial pancreatoduodenectomy for duodenal adenocarcinoma. LANGENBECKS ARCHIVES OF SURGERY, 404(4), 439-449. doi:10.1007/s00423-019-01779-wDOI: 10.1007/s00423-019-01779-w
Ghaneh, P., Kleeff, J., Halloran, C. M., Raraty, M., Jackson, R., Melling, J., . . . Smith, C. (2019). The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Annals of Surgery, 269(03), 520-529. doi:10.1097/SLA.0000000000002557DOI: 10.1097/SLA.0000000000002557
Sheel, A. R. G., Harrison, S., Sarantitis, I., Nicholson, J. A., Hanna, T., Grocock, C., . . . Greenhalf, W. (2019). Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.. The American Journal of Gastroenterology (Elsevier), 114(1), 155-164. doi:10.1038/s41395-018-0395-yDOI: 10.1038/s41395-018-0395-y
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma (PDAC) in the ESPAC-4 Randomized Adjuvant Chemotherapy Trial (Conference Paper)
Neoptolemos, J. P., Jones, R. P., Psarelli, E. E., Jackson, R., Ghaneh, P., Halloran, C. M., . . . Canc, E. S. G. P. (2019). Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma (PDAC) in the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. In PANCREAS Vol. 48 (pp. 1497-1498). Retrieved from http://gateway.webofknowledge.com/
hENT1 RNA and Protein in Combination May Act as Predictive Biomarkers for Survival for Patients Treated With Adjuvant Gemcitabine in Pancreatic Cancer (Conference Paper)
Hale, J., Evans, A., Aughton, K., Elander, N. O., Ghaneh, P., Neoptolemos, J. P., . . . Canc, E. S. G. P. (2019). hENT1 RNA and Protein in Combination May Act as Predictive Biomarkers for Survival for Patients Treated With Adjuvant Gemcitabine in Pancreatic Cancer. In PANCREAS Vol. 48 (pp. 1436-1437). Retrieved from http://gateway.webofknowledge.com/
2018
Mahajan, U. M., Langhoff, E., Goni, E., Costello, E., Greenhalf, W., Halloran, C. M., . . . Mayerle, J. (2018). Immune Cell and Stromal Signature Associated with Progression-free Survival of Patients with Resected Pancreatic Ductal Adenocarcinoma. Gastroenterology, 155(05), 1625-1639.E2. doi:10.1053/j.gastro.2018.08.009DOI: 10.1053/j.gastro.2018.08.009
Mohamed, E., Jackson, R., Halloran, C. M., & Ghaneh, P. (2018). Role of Radiological Imaging in the Diagnosis and Characterization of Pancreatic Cystic Lesions: A Systematic Review. PANCREAS, 47(9), 1055-1064. doi:10.1097/MPA.0000000000001134DOI: 10.1097/MPA.0000000000001134
Sheel, A. R. G., Baron, R. D., Sarantitis, I., Ramesh, J., Ghaneh, P., Raraty, M. G. T., . . . Neoptolemos, J. P. (2018). The diagnostic value of Rosemont and Japanese diagnostic criteria for 'indeterminate', 'suggestive', 'possible' and 'early' chronic pancreatitis. PANCREATOLOGY, 18(7), 774-784. doi:10.1016/j.pan.2018.08.002DOI: 10.1016/j.pan.2018.08.002
Mucinous Tumours of the Pancreas (Chapter)
Rao, R. G., Healey, P., & Halloran, C. M. (2018). Mucinous Tumours of the Pancreas. In Surgical Diseases of the Pancreas and Biliary Tree (pp. 311-332). Springer Singapore. doi:10.1007/978-981-10-8755-4_12DOI: 10.1007/978-981-10-8755-4_12
Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., . . . Canc, E. S. G. P. (2018). Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy. British Journal of Cancer, 118, 1084-1088. doi:10.1038/s41416-018-0005-1DOI: 10.1038/s41416-018-0005-1
Arterial Resection in Pancreatic Cancer (Chapter)
Dunne, D. F. J., Kleeff, J., Yip, V. S., Halloran, C., Ghaneh, P., & Neoptolemos, J. P. (2018). Arterial Resection in Pancreatic Cancer. In Pancreatic Cancer (pp. 1089-1104). Springer New York. doi:10.1007/978-1-4939-7193-0_72DOI: 10.1007/978-1-4939-7193-0_72
Gilbert, T., Baron, R., Ghaneh, P., & Halloran, C. (2018). Laparoscopic Staging in Patients with Newly Diagnosed Pancreatic Cancer. In Pancreatic Cancer (pp. 753-769). Springer New York. doi:10.1007/978-1-4939-7193-0_80DOI: 10.1007/978-1-4939-7193-0_80
Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., . . . Greenhalf, W. (2018). Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predict survival in pancreatic cancer.. British Journal of Cancer, 118(7), 947-954. doi:10.1038/s41416-018-0004-2DOI: 10.1038/s41416-018-0004-2
Halloran, C. M. (2018). Cytoplasmic HuR Status Predicts Disease-Free Survival in Resected Pancreatic Cancer: A Post-Hoc Analysis from the International Multi-Institutional Phase III ESPAC-3 Clinical Trial. Annals of Surgery, 267(2), 364-369. doi:10.1097/SLA.0000000000002088DOI: 10.1097/SLA.0000000000002088
Ghaneh, P., Hanson, R., Titman, A., Lancaster, G., Plumpton, C., Lloyd-Williams, H., . . . Neoptolemos, J. P. (2018). PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality (18)fluorine-2-fluoro-2-deoxy-D-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer. HEALTH TECHNOLOGY ASSESSMENT, 22(7), 1-+. doi:10.3310/hta22070DOI: 10.3310/hta22070
Neoptolemos, J. P., Halloran, C. M., Ghaneh, P., & Kleeff, J. (2018). Pancreatic Cancer and FOLFIRINOX: Should We Resect All Responders?. Ann Surg, 267(2), e35-e36. doi:10.1097/SLA.0000000000002026DOI: 10.1097/SLA.0000000000002026
Halloran, C. M. (n.d.). Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer.. JNCI: Journal of the National Cancer Institute.
2017
Oldfield, L., Rao, R., Purewal, T., Neoptolemos, J. P., Halloran, C. M., Greenhalf, W., & Costello, E. (2017). Detecting Pancreatic Cancer Earlier: Identifying Type 3c Diabetes in Individuals Newly Diagnosed With Type 2 Diabetes. In PANCREAS Vol. 46 (pp. 1425). Retrieved from http://gateway.webofknowledge.com/
Williams, D., Gana, T., Sivapalan, L., Butler, O., Jackson, R., Perez-Mancera, P., . . . Costello, E. (2017). Nrf2 in Pancreatic Cancer Chemotherapy Response and the Use of Brusatol as a Chemotherapeutic Agent. In PANCREAS Vol. 46 (pp. 1443). Retrieved from http://gateway.webofknowledge.com/
Rao, R. G., Costello, E., Halloran, C. M., Oldfield, L., Greenhalf, W., Ghaneh, P., . . . Mann, K. (2017). The Prevalence of Diabetes Mellitus is Significantly Higher for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma Compared to Surgery for Other Pancreatic Pathologies. In PANCREAS Vol. 46 (pp. 1403-1404). Retrieved from http://gateway.webofknowledge.com/
Diener, M. K., Hüttner, F. J., Kieser, M., Knebe, P., Dörr-Harim, C., Distler, M., . . . Hackert, T. (2017). Partial pancreatoduodenectomy versus duodenum-preserving pancreatic head resection in chronic pancreatitis: the multicentre, randomised, controlled, double-blind ChroPac trial. The Lancet, 390(10099), 1027-1037. doi:10.1016/S0140-6736(17)31960-8DOI: 10.1016/S0140-6736(17)31960-8
Drewes, A. M., Bouwense, S. A. W., Campbell, C. M., Ceyhan, G. O., Delhaye, M., Demir, I. E., . . . Yadav, D. (2017). Guidelines for the understanding and management of pain in chronic pancreatitis. Pancreatology, 17(05), 720-731. doi:10.1016/j.pan.2017.07.006DOI: 10.1016/j.pan.2017.07.006
Halloran, C. M. (2017). Pancreatic Anastomosis After Pancreatoduodenectomy:A Position Statement By The International Study Group Of Pancreatic Surgery (ISGPS). Surgery, 161(5), 1221-1234. doi:10.1016/j.surg.2016.11.021DOI: 10.1016/j.surg.2016.11.021
Psarelli, E. E., Jackson, R., Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Halloran, C. M., & Buechler, M. W. (2017). Beyond ESPAC-4: better surgery and systemic therapy. LANCET, 389(10078), 1517-1518. doi:10.1016/S0140-6736(17)30947-9DOI: 10.1016/S0140-6736(17)30947-9
Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., . . . Büchler, M. W. (2017). Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.. Lancet (London, England), 389(10073), 1011-1024. doi:10.1016/s0140-6736(16)32409-6DOI: 10.1016/s0140-6736(16)32409-6
2016
Chemotherapy and radiotherapy for pancreatic cancer (Chapter)
Halloran, C. M., Oldfield, F. E., & Neoptolemos, J. P. (2017). Chemotherapy and radiotherapy for pancreatic cancer. In Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set (pp. 1032-1041.e3). Elsevier. doi:10.1016/b978-0-323-34062-5.00068-6DOI: 10.1016/b978-0-323-34062-5.00068-6
Rizzato, C., Campa, D., Talar-Wojnarowska, R., Halloran, C., Kupcinskas, J., Butturini, G., . . . Canzian, F. (2016). Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patients. Carcinogenesis, 37(10), 957-964. doi:10.1093/carcin/bgw080DOI: 10.1093/carcin/bgw080
Kleeff, J., Costello, E., Jackson, R., Halloran, C., Greenhalf, W., Ghaneh, P., . . . Canc, E. S. G. P. (2016). The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer. BRITISH JOURNAL OF CANCER, 115(7), 887-894. doi:10.1038/bjc.2016.277DOI: 10.1038/bjc.2016.277
Ghaneh, P., Wong, W. L., Titman, A., Plumpton, C., Vinjamuri, S., Johnson, C., . . . Neoptolemos, J. P. (2016). PET-PANC: Multi-centre prospective diagnostic accuracy and clinical value trial of FDG PET/CT in the diagnosis and management of suspected pancreatic cancer.. In Journal of Clinical Oncology Vol. Vol 34. Chicago: American Society of Clinical Oncology.
Gomatos, I. P., Halloran, C., Ghaneh, P., Raraty, M., Polydoros, F., Campbell, F., . . . Neoptolemos, J. P. (2016). Management and Outcome of 64 Patients with Pancreatic Serous Cystic Neoplasms. DIGESTIVE SURGERY, 33(3), 203-212. doi:10.1159/000442094DOI: 10.1159/000442094
Halloran, C. M., Platt, K., Gerard, A., Polydoros, F., O'Reilly, D. A., Gomez, D., . . . Ghaneh, P. (2016). PANasta Trial; Cattell Warren versus Blumgart techniques of panreatico-jejunostomy following pancreato-duodenectomy: Study protocol for a randomized controlled trial. TRIALS, 17. doi:10.1186/s13063-015-1144-9DOI: 10.1186/s13063-015-1144-9
Gomatis, I., Halloran, C. M., Ghaneh, P., Raraty, M., Polydoros, F., Evans, J. C., . . . Neoptolemos, J. P. (2016). Outcomes From Minimal Access Retroperitoneal and Open Pancreatic Necrosectomy in 394 Patients With Necrotizing Pancreatitis. Annals of Surgery, 263(5), 992-1001. doi:10.1097/SLA.0000000000001407DOI: 10.1097/SLA.0000000000001407
2015
Sultana, A., Jackson, R., Gilbert, T., Bostock, E., Psarelli, E., Cox, T., . . . Halloran, C. (2015). What Is the Best Way to Identify MalignantTransformation Within Pancreatic IPMN: A SystematicReview and Meta-Analyses. Clinical and Translational Gastroenterology, 6(12), e130. doi:10.1038/ctg.2015.60DOI: 10.1038/ctg.2015.60
Investigating Gemcitabine-Loaded Superparamagnetic Iron Oxide Nanoparticles Against Pancreatic Cancer Cells in Artificial Circulation (Journal article)
Nandi, S., Sykes, P. D., Hasan, E., Barrow, M., Costello, E., Rosseinsky, M. J., . . . Halloran, C. M. (2015). Investigating Gemcitabine-Loaded Superparamagnetic Iron Oxide Nanoparticles Against Pancreatic Cancer Cells in Artificial Circulation. PANCREAS, 44(8), 1401. Retrieved from https://www.webofscience.com/
Evidence of Adjuvant Chemotherapy of Ductal Pancreatic Cancer (Chapter)
Sultana, A., Halloran, C., Palmer, D., Ghaneh, P., Cox, T., & Neoptolemos, J. P. (n.d.). Evidence of Adjuvant Chemotherapy of Ductal Pancreatic Cancer. In Pancreatic Cancer, Cystic Neoplasms and Endocrine Tumors (pp. 94-102). John Wiley & Sons, Ltd. doi:10.1002/9781118307816.ch12DOI: 10.1002/9781118307816.ch12
Biomarkers for early diagnosis of pancreatic cancer (Journal article)
Jenkinson, C., Earl, J., Ghaneh, P., Halloran, C., Carrato, A., Greenhalf, B., . . . Costello-Goldring, E. (2015). Biomarkers for early diagnosis of pancreatic cancer. Expert Review of Gastroenterology & Hepatology, 9(03), 305-315. doi:10.1586/17474124.2015.965145DOI: 10.1586/17474124.2015.965145
Adjuvant Therapy in Pancreatic Cancer (Journal article)
Oldfield, F., Ghaneh, P., Jackson, R., & Halloran, C. (n.d.). Adjuvant Therapy in Pancreatic Cancer. International Journal of Digestive Diseases, 01(01). doi:10.4172/2472-1891.100003DOI: 10.4172/2472-1891.100003
Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac. (Journal article)
Nicholson, J., Greenhalf, B., Jackson, R., Cox, T., Butler, J., Hanna, T., . . . Neoptolemos, J. (2015). Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.. Pancreas, 44(02), 260-265. doi:10.1097/MPA.0000000000000246DOI: 10.1097/MPA.0000000000000246
2014
Adjuvant therapy in pancreatic cancer (Journal article)
Jones, O. P., Melling, J. D., & Ghaneh, P. (2014). Adjuvant therapy in pancreatic cancer. WORLD JOURNAL OF GASTROENTEROLOGY, 20(40), 14733-14746. doi:10.3748/wjg.v20.i40.14733DOI: 10.3748/wjg.v20.i40.14733
Shaw, V. E., Lane, B., Jenkinson, C., Cox, T., Greenhalf, W., Halloran, C. M., . . . Costello, E. (2014). Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease.. Molecular cancer, 13, 114. doi:10.1186/1476-4598-13-114DOI: 10.1186/1476-4598-13-114
Serum cytokine biomarker panels for discriminating Pancreatic Cancer from Benign Pancreatic Disease (Journal article)
Shaw, V. E., Lane, B., Jenkinson, C., Cox, T. F., Greenhalf, W., Halloran, C. M., . . . Costello, E. (2014). Serum cytokine biomarker panels for discriminating Pancreatic Cancer from Benign Pancreatic Disease. Molecular Cancer, 13. Retrieved from https://molecular-cancer.biomedcentral.com/articles/10.1186/1476-4598-13-114
Prognostic markers in acute pancreatitis (Journal article)
Gomatos, I. P., Xiaodong, X., Ghaneh, P., Halloran, C., Raraty, M., Lane, B., . . . Neoptolemos, J. P. (2014). Prognostic markers in acute pancreatitis. Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare, 14(3), 333-346. doi:10.1586/14737159.2014.897608DOI: 10.1586/14737159.2014.897608
Develoment of superparamagnetic nano particles that specifically deliver intracellular chemotherapy to pancreatic cancer cell lines by antibody mediated magneto-taxis (Journal article)
Sykes, P. D., Nandi, S., Rossenisky, M., & Halloran, C. M. (2014). Develoment of superparamagnetic nano particles that specifically deliver intracellular chemotherapy to pancreatic cancer cell lines by antibody mediated magneto-taxis. Nature Nano.
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial. (Journal article)
Greenhalf, W., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Lamb, R. F., . . . Büchler, M. W. (2014). Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial.. Journal of the National Cancer Institute, 106(1). doi:10.1093/jnci/djt347DOI: 10.1093/jnci/djt347
2013
Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: A meta-analysis (Journal article)
Huang, W., Altaf, K., Jin, T., Xiong, J. -J., Wen, L., Javed, M. A., . . . Xia, Q. (2013). Prediction of the severity of acute pancreatitis on admission by urinary trypsinogen activation peptide: A meta-analysis. WORLD JOURNAL OF GASTROENTEROLOGY, 19(28), 4607-4615. doi:10.3748/wjg.v19.i28.4607DOI: 10.3748/wjg.v19.i28.4607
Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis (Journal article)
Hall, A. M., Poole, L. A. L., Renton, B., Wozniak, A., Fisher, M., Neal, T., . . . Hampshire, P. A. (2013). Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis. CRITICAL CARE, 17(2). doi:10.1186/cc12569DOI: 10.1186/cc12569
Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis. (Journal article)
Hall, A., Poole, L., Renton, B., Wozniak, A., Fisher, M., Neal, T., . . . Hampshire, P. A. (2013). Prediction of invasive candidal infection in critically ill patients with severe acute pancreatitis.. Crit Care, 17(2), R49.
2012
Chemotherapy and radiotherapy for pancreatic and periampullary cancer (Chapter)
Halloran, C. M., Ghaneh, P., & Neoptolemos, J. P. (2012). Chemotherapy and radiotherapy for pancreatic and periampullary cancer. In Blumgart's Surgery of the Liver, Pancreas and Biliary Tract (pp. 972-978.e2). Elsevier. doi:10.1016/b978-1-4377-1454-8.00063-1DOI: 10.1016/b978-1-4377-1454-8.00063-1
Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial (Journal article)
Neoptolemos, J. P., Moore, M. J., Cox, T. F., Valle, J. W., Palmer, D. H., McDonald, A. C., . . . Canc, E. S. G. P. (2012). Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma The ESPAC-3 Periampullary Cancer Randomized Trial. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 308(2), 147-156. doi:10.1001/jama.2012.7352DOI: 10.1001/jama.2012.7352
Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer (Journal article)
Sykes, P. D., Neoptolemos, J. P., Costello, E., & Halloran, C. M. (2012). Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 6(3), 343-356. doi:10.1586/EGH.12.13DOI: 10.1586/EGH.12.13
Molecular Biology of Pancreatic Cancer. (Chapter)
Sykes, P., Costello, E., Neoptolemos, J. P., & Halloran, C. M. (2012). Molecular Biology of Pancreatic Cancer.. In Oxford Textbook of Oncology (pp. TBC). Oxford: Oxford.
Sykes, P. D., Neoptolemos, J. P., Costello, E., & Halloran, C. M. (2012). Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer.. Expert Rev Gastroenterol Hepatol., 6(3), 343-356.
2011
Olariu, C. I., Yiu, H. H. P., Bouffier, L., Nedjadi, T., Costello, E., Williams, S. R., . . . Rosseinsky, M. J. (2011). Multifunctional Fe3O4 nanoparticles for targeted bi-modal imaging of pancreatic cancer. JOURNAL OF MATERIALS CHEMISTRY, 21(34), 12650-12659. doi:10.1039/c1jm11370dDOI: 10.1039/c1jm11370d
Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial (Journal article)
Diener, M. K., Seiler, C. M., Rossion, I., Kleeff, J., Glanemann, M., Butturini, G., . . . Buechler, M. W. (2011). Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. LANCET, 377(9776), 1514-1522. doi:10.1016/S0140-6736(11)60237-7DOI: 10.1016/S0140-6736(11)60237-7
Chemotherapy and Radiotherapy: Adjuvant, Neo-Adjuvant and Palliative. (Chapter)
Halloran, C., Ghaneh, P., & Neoptolemos, J. P. (2011). Chemotherapy and Radiotherapy: Adjuvant, Neo-Adjuvant and Palliative.. In M. W. Buchler (Ed.), Blumgart's Surgery of the Liver, Pancreas and Biliary Tract, 5th Ed. (pp. 63A). Philadelphia: Elsevier.
Partial Pancreatic Resection for Pancreatic Malignancy Is Associated with Sustained Pancreatic Exocrine Failure and Reduced Quality of Life: A Prospective Study (Journal article)
Halloran, C. M., Cox, T. F., Chauhan, S., Raraty, M. G. T., Sutton, R., Neoptolemos, J. P., & Ghaneh, P. (2011). Partial Pancreatic Resection for Pancreatic Malignancy Is Associated with Sustained Pancreatic Exocrine Failure and Reduced Quality of Life: A Prospective Study. PANCREATOLOGY, 11(6), 535-545. doi:10.1159/000333308DOI: 10.1159/000333308
Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study (Journal article)
Halloran, C. M., Cox, T. F., Chauhan, S., Raraty, M. G., Sutton, R., Neoptolemos, J. P., & Ghaneh, P. (2011). Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study. Pancreatology, 11(6), 535-545.
2010
Authors' reply: PBD treatment of cancer of the head of the pancreas (Journal article)
Neoptolemos, J. P., Lombard, M., & Halloran, C. M. (2010). Authors' reply: PBD treatment of cancer of the head of the pancreas. NATURE REVIEWS CLINICAL ONCOLOGY, 7(11). doi:10.1038/nrclinonc.2010.45-c2DOI: 10.1038/nrclinonc.2010.45-c2
Minimal Access Retroperitoneal Pancreatic Necrosectomy Improvement in Morbidity and Mortality With a Less Invasive Approach (Journal article)
Raraty, M. G. T., Halloran, C. M., Dodd, S., Ghaneh, P., Connor, S., Evans, J., . . . Neoptolemos, J. P. (2010). Minimal Access Retroperitoneal Pancreatic Necrosectomy Improvement in Morbidity and Mortality With a Less Invasive Approach. ANNALS OF SURGERY, 251(5), 787-793. doi:10.1097/SLA.0b013e3181d96c53DOI: 10.1097/SLA.0b013e3181d96c53
SURGICAL ONCOLOGY PBD-better stents in specialized centers are needed (Journal article)
Neoptolemos, J. P., & Halloran, C. M. (2010). SURGICAL ONCOLOGY PBD-better stents in specialized centers are needed. NATURE REVIEWS CLINICAL ONCOLOGY, 7(5), 244-246. doi:10.1038/nrclinonc.2010.45DOI: 10.1038/nrclinonc.2010.45
ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial (Journal article)
Diener, M. K., Bruckner, T., Contin, P., Halloran, C., Glanemann, M., Schlitt, H. J., . . . Seiler, C. M. (2010). ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial. TRIALS, 11. doi:10.1186/1745-6215-11-47DOI: 10.1186/1745-6215-11-47
Multifunctional nanoparticles for healthcare applications (Journal article)
Olariu, C. I., Yiu, H. P. P., Bouffier, L., Nedjadi, T., Costello, E., Halloran, C. M., & Rosseinsky, M. J. (2010). Multifunctional nanoparticles for healthcare applications. European Cells and Materials, 20(SUPPL.3), 192.
Surgical oncology: PBD-better stents in specialized centers are needed, a response (Journal article)
Neoptolemos, J. P., Halloran, C. M., & Lombard, M. G. (2010). Surgical oncology: PBD-better stents in specialized centers are needed, a response. Nature reviews clinical oncology - submitted.
2009
A spllen-preserving approach to pancreatic resection: Indications and complications (Journal article)
Gardener-Thorpe, J., Ghaneh, P., Wheelan, P., Joshi, H. M. N., Al-sarireh, B., Halloran, C. M., . . . Sutton, R. (2009). A spllen-preserving approach to pancreatic resection: Indications and complications. British Journal of Surgery.
2008
Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy (Journal article)
Halloran, C. M., Ghaneh, P., Connor, S., Sutton, R., Neoptolemos, J. P., & Raraty, M. G. T. (2008). Carbohydrate antigen 19.9 accurately selects patients for laparoscopic assessment to determine resectability of pancreatic malignancy. BRITISH JOURNAL OF SURGERY, 95(4), 453-459. doi:10.1002/bjs.6043DOI: 10.1002/bjs.6043
2005
Trials of gene therapy for pancreatic carcinoma (Journal article)
Halloran, C. M., Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2005). Trials of gene therapy for pancreatic carcinoma. Current Gastroenterology Reports, 7(3), 165-169. doi:10.1007/s11894-005-0028-7DOI: 10.1007/s11894-005-0028-7
Combination Chemo-Gene Therapy for Pancreatic cancer (Thesis / Dissertation)
Halloran, C. (2005). Combination Chemo-Gene Therapy for Pancreatic cancer. (PhD Thesis, The University of Liverpool).
The european working time directive 'triple whammy': Hitting trainees where it hurts (Journal article)
Heath, R. E., Gate, T., Halloran, C., Callaghan, M., Paraoan, M., & Blair, S. D. (2005). The european working time directive 'triple whammy': Hitting trainees where it hurts. British Journal of Surgery, 92, 113.
Trials of gene therapy for pancreatic carcinoma. (Journal article)
Halloran, C. M., Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2005). Trials of gene therapy for pancreatic carcinoma.. Current gastroenterology reports, 7(3), 165-169. doi:10.1007/s11894-005-0028-7DOI: 10.1007/s11894-005-0028-7
2004
Current standards of surgery for pancreatic cancer (Journal article)
Alexakis, N., Halloran, C., Raraty, M., Ghaneh, P., Sutton, R., & Neoptolemos, J. P. (2004). Current standards of surgery for pancreatic cancer. BRITISH JOURNAL OF SURGERY, 91(11), 1410-1427. doi:10.1002/bjs.4794DOI: 10.1002/bjs.4794
5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16(INK4A) greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells (Journal article)
Halloran, C. M., Ghaneh, P., Shore, S., Greenhalf, W., Zumstein, L., Wilson, D., . . . Costello, E. (2004). 5-Fluorouracil or gemcitabine combined with adenoviral-mediated reintroduction of p16(INK4A) greatly enhanced cytotoxicity in Panc-1 pancreatic adenocarcinoma cells. JOURNAL OF GENE MEDICINE, 6(5), 514-525. doi:10.1002/jgm.540DOI: 10.1002/jgm.540
Novel alternatives to chemotherapy in advanced disease - gene transfer. (Chapter)
Ghaneh, P., Halloran, C. M., Costello, E., & Neoptolemos, J. P. (2004). Novel alternatives to chemotherapy in advanced disease - gene transfer.. In C. D. Johnson, & C. W. Imrie (Eds.), Pancreatic Disease, Basic Science and Clinical Management (pp. 99-120). London: Springer-Verlag.
2003
Pancreatic adenocarcinoma - gene therapy is better adjuvant treatment than chemotherapy or radiotherapy (Journal article)
Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2003). Pancreatic adenocarcinoma - gene therapy is better adjuvant treatment than chemotherapy or radiotherapy. Pancreatology, 3(3), 245.
2002
Complications of pancreatic cancer resection (Journal article)
Halloran, C. M., Ghaneh, P., Bosonnet, L., Hartley, M. N., Sutton, R., & Neoptolemos, J. P. (2002). Complications of pancreatic cancer resection. DIGESTIVE SURGERY, 19(2), 138-146. doi:10.1159/000052029DOI: 10.1159/000052029
Complications of pancreatic cancer resection (Journal article)
Halloran, C. M., Ghaneh, P., Bossnett, L., Hartley, M., Sutton, R., & Neoptolemos, J. P. (2002). Complications of pancreatic cancer resection. Digestive Surgery, 19(2), 138-146. doi:10.1159/000052029DOI: 10.1159/000052029
The combined approach of Chemo-Gene therapy in the treatment of pancreatic adenocarcinoma (Journal article)
Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2002). The combined approach of Chemo-Gene therapy in the treatment of pancreatic adenocarcinoma. Pancreatology, 2(3), 322.
2001
Cytotoxic drugs combined with adenoviral-mediated introduction of tumour suppresser genes act synergistically to decrease pancreatic cancer cell viability (Journal article)
Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2001). Cytotoxic drugs combined with adenoviral-mediated introduction of tumour suppresser genes act synergistically to decrease pancreatic cancer cell viability. Pancreatology, 1(2), 164.
The effects of combining cytotoxic agents and adenoviral mediated introduction of tumour suppresser genes on pancreatic cancer cells (Journal article)
Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2001). The effects of combining cytotoxic agents and adenoviral mediated introduction of tumour suppresser genes on pancreatic cancer cells. Molecular Therapy, 3(5), 213-214.
gene therapy for pancreatic cancer; cobination of cytotoxic agents with adenoviral-delivered tumour suppresser genes increases cytopathic effect (Journal article)
Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2001). gene therapy for pancreatic cancer; cobination of cytotoxic agents with adenoviral-delivered tumour suppresser genes increases cytopathic effect. British Journal of Surgery, 88(1), 7.
2000
An investigation into the effects, on pancreatic cancer cells, of chemotherapeutic drugs and adenoviral-mediated delivery of p53 and p16 (Journal article)
Halloran, C., Ghaneh, P., Greenhalf, W., Neoptolemos, J. P., & Costello, E. (2000). An investigation into the effects, on pancreatic cancer cells, of chemotherapeutic drugs and adenoviral-mediated delivery of p53 and p16. Molecular Therapy, 1(5), 325-326.
Fatal intestinal perforation secondary to fragmentation of a celestin tube (Journal article)
Evans, J. D., Halloran, C. M., Mansour, P., & Zeiderman, M. R. (2000). Fatal intestinal perforation secondary to fragmentation of a celestin tube. DIGESTIVE SURGERY, 17(4), 400-402. doi:10.1159/000018886DOI: 10.1159/000018886
Gene therapy for pancreatic cancer - current and prospective strategies (Journal article)
Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2000). Gene therapy for pancreatic cancer - current and prospective strategies. SURGICAL ONCOLOGY-OXFORD, 9(4), 181-191. doi:10.1016/S0960-7404(01)00011-1DOI: 10.1016/S0960-7404(01)00011-1
gene therapy for pancreatic cancer - current and propective strategies (Journal article)
Halloran, C. M., Ghaneh, P., Neoptolemos, J. P., & Costello, E. (2000). gene therapy for pancreatic cancer - current and propective strategies. Surgical Oncology, 9(4), 181-191.
